Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients

Autor: Pruett, T.L., McGory, R.W., Wright, F.H., Pescovitz, M.D., Yang, H., McClain, J.B.
Zdroj: In Transplantation Proceedings 2009 41(9):3655-3661
Databáze: ScienceDirect